ImportantUpdates

Concord Biotech successfully completed a NAFDAC inspection at its Valthera Oral Solid Dosage Unit-2 facility.

Concord Biotech Limited logo
Concord Biotech LimitedCONCORDBIO · Filed with the exchange

This reinforces the company's commitment to high quality, safety, and global regulatory compliance, supporting continued market access and operational stability.

Read the original filing(PDF)

No comments yet. Be the first.

More from Concord Biotech Limited

All announcements